Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.16 USD | +0.81% |
|
-1.52% | -0.92% |
06-11 | Japan's Nikkei rises on US stocks, heavyweight chip shares | RE |
05-28 | Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With an expected P/E ratio at 35.68 and 30.29 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.27 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.92% | 24.05B | - | ||
-4.33% | 183B | C+ | ||
-1.63% | 104B | C | ||
-3.25% | 68.18B | A | ||
+16.54% | 47.14B | B- | ||
-10.90% | 43.97B | B- | ||
+6.78% | 40.95B | B+ | ||
+19.87% | 31.05B | B | ||
-6.00% | 24.11B | A- | ||
-10.88% | 22.31B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4543 Stock
- TRUMY Stock
- Ratings Terumo Corporation